hypercalcemia disease
hypercalcemia disease
Explore linked clinical trials. Standard reference: MONDO:00015669 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The GranStone Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Foreign Bodies, Foreign-Body Reaction, Granuloma, Granuloma, Foreign-Body, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hypercalcemia disease, injury, kidney disorder, metabolic disease, nephrocalcinosis, nephrolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-18 | NCT07828002 | |
| Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, adrenal gland disorder, bone disorder, brain disorder, calcium metabolic disease, central nervous system disorder, endocrine system disorder, hypercalcemia disease, hyperparathyroidism, hypothalamic disorder, metabolic disease, musculoskeletal system disorder, nervous system disorder, osteoporosis, parathyroid gland disorder, pituitary gland disorder, primary hyperparathyroidism, thyroid gland disorder | Recruiting | Not stated | 2026-09-17 | NCT07824102 | |
| Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypercalcemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hereditary disease, hypercalcemia disease, hypercalcemia, infantile, kidney disorder, metabolic disease, nephrocalcinosis, urinary system disorder | Recruiting | Phase 2 | 2026-06-22 | NCT03301038 | |
| Hypercalcemia After Paraffin Oil Injection | Granuloma, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Water-Electrolyte Imbalance, calcium metabolic disease, hypercalcemia disease, lymphatic system disorder, lymphoproliferative syndrome, metabolic disease | Recruiting | Not stated | 2025-04-06 | NCT04292288 | |
| COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable | Apnea, Arrhythmias, Cardiac, Atrial Remodeling, Cardiac Conduction System Disease, Cardiac Output, Low, Cardiomyopathies, Primary, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Consciousness Disorders, Dyssomnias, Heart Decompensation, Hyperkalemia, Hypertrophy, Hypocalcemia, Infarction, Necrosis, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiration Disorders, ST-elevation myocardial infarction, Signs and Symptoms, Sleep Disorders, Intrinsic, Syncope, Unconsciousness, Ventricular Dysfunction, Ventricular Dysfunction, Left, Water-Electrolyte Imbalance, atrial fibrillation, atrioventricular dissociation, calcium metabolic disease, cardiomyopathy, cardiovascular disorder, congenital heart disease, heart disorder, heart failure, hypercalcemia disease, ischemic disease, metabolic disease, myocardial infarction, myocardial ischemia, nervous system disorder, obstructive sleep apnea syndrome, pericarditis, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, vascular disorder | Enrolling by invitation | Not stated | 2025-01-08 | NCT06763549 | |
| Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital | Disease Attributes, Emergencies, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Water-Electrolyte Imbalance, calcium metabolic disease, hypercalcemia disease, metabolic disease | Active, not recruiting | Not stated | 2024-12-09 | NCT06467877 | |
| Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil | Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, calcium metabolic disease, hypercalcemia disease, metabolic disease | Recruiting | Not stated | 2024-10-01 | NCT04265599 | |
| Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity | Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, calcium metabolic disease, endocrine system disorder, hypercalcemia disease, hyperparathyroidism, metabolic disease, parathyroid gland disorder, primary hyperparathyroidism | Recruiting | Phase 4 | 2024-09-19 | NCT03935984 | |
| Registry for Hypoparathyroidism Wuerzburg | Hypocalcemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, calcium metabolic disease, hypercalcemia disease, metabolic disease | Recruiting | Not stated | 2022-11-08 | NCT05585593 |